Company: LIMN
Filing Date: 2025-01-16
Form Type: POS AM
Source: 0001104659-25-003835
Chunk: 776

Company: Liminatus Pharma, Inc.
Filing Date: 2025-01-16
Form: POS AM
Chunk 776
---
 Holding Corp.

By:

/s/ Chris Kim

Name:

Chris Kim

Title:

CEO, Secretary and Treasurer

### SUBSCRIBER
Ewon Comfortech Co., Ltd.

By:

/s/ Kyeong Hoon

Name:

Kyeong Hoon

Title:

President

### LIMINATUS
Liminatus Pharma, LLC

By:

/s/ Chris Kim

Name:

Chris Kim

Title:

CEO, Secretary and Treasurer

<div align='center'>E-38</div>

TABLE OF CONTENTS

#### Annex F​

#### EXECUTION VERSION​

### SPONSOR FORFEITURE AGREEMENT
This Sponsor Forfeiture Agreement (this “ Agreement ”) is entered into as of November 30, 2022, by and between Iris Acquisition Holdings LLC, a Delaware limited liability company (the “ Sponsor ”) and Iris Acquisition Corp, a Delaware corporation (the “SPAC”). Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Business Combination Agreement (as defined below).

<div align='center'>W I T N E S S E T H:</div>

WHEREAS, the Sponsor currently holds 4,177,778 Private Placement Warrants;

WHEREAS, on November 30, 2022, Iris Parent Holding Corp., a Delaware corporation (“ ParentCo ”), SPAC, Liminatus Pharma Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of ParentCo, SPAC Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of ParentCo, and Liminatus Pharma, LLC, a Delaware limited liability company entered into that certain Business Combination Agreement (the “ Business Combination Agreement ”), which provides, among other things, that, upon the terms and subject to the conditions thereof, (i) Liminatus Merger Sub will be merged with and into the Company, with the Company as the surviving entity and a wholly owned subsidiary of ParentCo, and (ii) immediately following the transaction described in (i), SPAC Merger Sub will be merged with and into SPAC, with SPAC surviving the SPAC Merger as a direct wholly owned subsidiary of ParentCo; and

NOW, THEREFORE, in consideration of the foregoing and of the mutual covenants herein contained and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto hereby agree as follows:

1. Immediately prior to the Closing and after giving effect to the redemption of SPAC Shares, Sponsor hereby